COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety

To date, four vaccines have been authorised for emergency use and under conditional approval by the European Medicines Agency to prevent COVID-19: Comirnaty, COVID-19 Vaccine Janssen, Spikevax (previously COVID-19 Vaccine Moderna) and Vaxzevria (previously COVID-19 Vaccine AstraZeneca). Although the...

Descripción completa

Detalles Bibliográficos
Autores principales: Luxi, Nicoletta, Giovanazzi, Alexia, Capuano, Annalisa, Crisafulli, Salvatore, Cutroneo, Paola Maria, Fantini, Maria Pia, Ferrajolo, Carmen, Moretti, Ugo, Poluzzi, Elisabetta, Raschi, Emanuel, Ravaldi, Claudia, Reno, Chiara, Tuccori, Marco, Vannacci, Alfredo, Zanoni, Giovanna, Trifirò, Gianluca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569292/
https://www.ncbi.nlm.nih.gov/pubmed/34739716
http://dx.doi.org/10.1007/s40264-021-01131-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569292/
https://www.ncbi.nlm.nih.gov/pubmed/34739716
http://dx.doi.org/10.1007/s40264-021-01131-6

Ejemplares similares